|
| 38036767 | BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance. | Nat Immunol | 2024 |
| 37163615 | Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine. | Sci Transl Med | 2023 |
| 37766247 | Atovaquone and Pibrentasvir Inhibit the SARS-CoV-2 Endoribonuclease and Restrict Infection In Vitro but Not In Vivo. | | 2023 |
| 37670110 | A wild boar cathelicidin peptide derivative inhibits severe acute respiratory syndrome coronavirus-2 and its drifted variants. | | 2023 |
| 37662390 | Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity. | | 2023 |
| 37822504 | Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults. | | 2023 |
| 37808679 | Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera. | bioRxiv | 2023 |
| 37990024 | BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer. | | 2023 |
| 37986823 | Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates. | bioRxiv | 2023 |
| 37801035 | Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity. | FASEB J | 2023 |
| 37790523 | Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity. | | 2023 |
| 37708028 | Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron. | | 2023 |
| 38076895 | Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates. | | 2023 |
| 37703370 | IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus. | Sci Adv | 2023 |
| 37090559 | Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults. | | 2023 |
| 36511813 | Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections. | Blood Cancer Discov | 2023 |
| 37023746 | Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques. | Cell Rep Med | 2023 |
| 36711543 | Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2. | bioRxiv | 2023 |
| 36951954 | Durability of immune responses to mRNA booster vaccination against COVID-19. | J Clin Invest | 2023 |
| 36880581 | Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice. | | 2023 |
| 36700653 | Virology under the Microscope-a Call for Rational Discourse. | mSphere | 2023 |
| 36700642 | Virology under the Microscope-a Call for Rational Discourse. | mBio | 2023 |
| 36700640 | Virology under the Microscope-a Call for Rational Discourse. | J Virol | 2023 |
| 37451878 | COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn. | Vaccine | 2023 |
| 37451078 | Treatment with sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaques. | | 2023 |
| 37191508 | Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates. | | 2023 |
| 36622349 | Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies. | | 2023 |
| 36546661 | Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster. | | 2023 |
| 36732946 | Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2. | Cell Rep | 2023 |
| 37167972 | Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response. | | 2023 |
| 36791207 | An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. | Sci Transl Med | 2023 |
| 37352211 | Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. | PLoS One | 2023 |
| 37225997 | Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans. | Nature | 2023 |
| 35262095 | The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization. | medRxiv | 2022 |
| 35976000 | Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults. | Journal of Virology | 2022 |
| 35907675 | Innate antiviral immunity: how prior exposures can guide future responses. | Trends Immunol | 2022 |
| 35765315 | Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies. | Open Forum Infect Dis | 2022 |
| 35703544 | The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization. | mSphere | 2022 |
| 35447072 | mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron. | Cell | 2022 |
| 35759727 | Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant. | Journal of Clinical Oncology | 2022 |
| 35436146 | Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia. | Journal of Clinical Oncology | 2022 |
| 35746552 | Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses. | Vaccines | 2022 |
| 35427477 | Vaccine protection against the SARS-CoV-2 Omicron variant in macaques. | Cell | 2022 |
| 35620424 | Contrasting behavior between the three human monocyte subsets in dengue pathophysiology. | iScience | 2022 |
| 35420471 | Erratum for Vanderheiden et al., "CCR2 Signaling Restricts SARS-CoV-2 Infection". | mBio | 2022 |
| 35798000 | Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. | Cell Rep Med | 2022 |
| 35734087 | COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004). | | 2022 |
| 36197988 | Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody. | Science advances | 2022 |
| 35547849 | Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim Analysis. | | 2022 |
| 35480625 | Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination. | Cell Reports Medicine | 2022 |